Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
No MRI evidence of cortical lesions in neuromyelitis optica.
Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]
[Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review).]
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Intermittent Atrioventricular Block following Fingolimod Initiation.

Pages